e.ferrari

TL2 · Turku

Contributes reviews on supplier material. Based in Turku.

Joined 7 May 2025 · last posted 3d

84 posts, newest first. Showing up to 150.

What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #47 · Compounds › Retatrutide · 25 Jul 2026 · 2 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Journal club: what we got wrong in an earlier session Replied, post #113 · Evidence › Journal club · 23 Jul 2026 · 10 likes Post #110 is the version of this I will quote in future. One addition. The baseline characteristics table is the single most useful page for the questions that get…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #28 · Evidence › Meta-analyses · 19 Jul 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Here for the analytics and not much else Replied, post #25 · Lounge › Introductions · 12 Jul 2026 · 1 like Clinician voices are genuinely welcome and are asked to be explicit about the line. Several members here say plainly in every post that they are describing general…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #131 · Sourcing › Logistics · 11 Jul 2026 · 3 likes This is the answer, and the reason it is the answer is the more useful part.
Micro-titration: a disputed topic, argued properly — one year on Replied, post #61 · Practice › Dosing & titration · 10 Jul 2026 · 1 like Picking up post #59: that is the part I would want checked first. A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An…
Insurance and replacement policies, compared Replied, post #75 · Sourcing › Logistics · 9 Jul 2026 · 6 likes Understood. Thank you for being specific about the limits of it.
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Started this topic · Compounds › Tirzepatide · 9 Jul 2026 · 23 likes What the GIP component of tirzepatide is thought to contribute, and how confident we can be I have a specific reason for asking rather than idle curiosity, and the…
Aggregate verification data across the directory, with caveats Replied, post #33 · Sourcing › Independent verification · 7 Jul 2026 · 12 likes I read post #29 twice before replying, because I had assumed the opposite. The arithmetic on aggregate verification data is the easy part and it is where the errors…
Pooling trials with different estimands Replied, post #51 · Evidence › Meta-analyses · 26 Jun 2026 · 23 likes I would keep pooling trials with different estimands and the decision it usually gets used for separate in this thread. They are related and they are not the same…
Angle of injection and whether 90 degrees is always right — the long version Replied, post #26 · Practice › Administration · 18 Jun 2026 · 0 likes The single most common technique error described here is drawing to the wrong graduation because the barrel was read at an angle. Read it straight on, at eye level,…
Reading a trial's population section before its results Replied, post #110 · Evidence › Trials · 10 Jun 2026 · 0 likes Post #107 answers the question as asked. The question underneath it is different. Risk of bias: structured appraisal of internal validity. Key things to assess:…
Stability of BPC-157 in solution: what has been measured Replied, post #2 · Compounds › Repair & healing peptides · 8 Jun 2026 · 6 likes Stability in solution is the practical constraint. Dry, these keep well; reconstituted, the supplier's own data usually covers a shorter period than people assume.
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #85 · Practice › Storage & stability · 7 Jun 2026 · 5 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
Pages past their review date, listed — does this still hold? Replied, post #5 · Meta › Wiki maintenance · 7 Jun 2026 · 3 likes My understanding of Pages past is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Peak-to-trough ratio at steady state for a weekly agent Replied, post #52 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 4 likes I would keep peak-to-trough ratio and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #38 · Analytics › Home & field testing · 29 May 2026 · 0 likes The version of Reflectance and photometric devices that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
What I would want from a home test that does not exist yet — what changed since Replied, post #34 · Analytics › Home & field testing · 28 May 2026 · 23 likes A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory.…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #22 · Analytics › Method validation · 27 May 2026 · 15 likes Picking up post #20: that is the part I would want checked first. The most useful reply I ever got about specificity was a request to state my units. It sounds like…
Blind submission and why it changes minds — the long version Replied, post #94 · Sourcing › Independent verification · 24 May 2026 · 7 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #64 · Sourcing › Vendor reports · 10 May 2026 · 1 like Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. I have left out the…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #135 · Pharmacology › Pharmacokinetics · 9 May 2026 · 0 likes Washout has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #39 · Practice › Reconstitution · 8 May 2026 · 4 likes Post #36 is right about the mechanism and I think understates the practical bit. A vial that will not fully dissolve: check in order: is the diluent genuinely room…
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Replied, post #5 · Compounds › Secretagogues & GH axis · 3 May 2026 · 11 likes Coming back to the opening post, because the follow-up matters more than the original answer. Secretagogues and glucose tolerance: there is a mechanistic concern that…
Moderation log format change Replied, post #48 · Meta › Announcements · 28 Apr 2026 · 1 like I read post #46 twice before replying, because I had assumed the opposite. Implementation timeline: announcements include when a change takes effect. Marking the date…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #13 · Practice › Administration · 9 Apr 2026 · 22 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Batch numbers that do not match the vial label Replied, post #3 · Sourcing › Red flags · 5 Apr 2026 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Reporting something here requires the batch, the date, the method and the…
Journal club: is percentage weight change the right endpoint? Replied, post #23 · Evidence › Journal club · 29 Mar 2026 · 14 likes Answering the question post #21 raises rather than the one it answers. The most common failure mode is spending fifty minutes on the effect size and ten on the…
About the Regulatory category Replied, post #4 · Sourcing › Regulatory · 16 Mar 2026 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Measurement error in home scales, with a worked standard deviation Replied, post #12 · Research Methods › Statistics · 23 Feb 2026 · 0 likes Two questions I would want answered before drawing anything from the measurement error in home scales data above: how were the cases selected, and what happened to the…
Trifluoroacetate content and its consequences Replied, post #100 · Analytics › Impurities & related substances · 7 Feb 2026 · 0 likes The strongest argument against my own position on trifluoroacetate content, stated as well as I can state it, since nobody else has yet.
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #23 · Analytics › Mass spectrometry · 31 Jan 2026 · 2 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
Heterogeneity as information rather than as a nuisance Replied, post #79 · Evidence › Meta-analyses · 28 Jan 2026 · 19 likes My experience of heterogeneity contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
The most common factual error about semaglutide on the internet — what changed since Replied, post #15 · Compounds › Semaglutide · 27 Jan 2026 · 30 likes Narrowing post #12, because the general version has more than one answer. Injection site does not appear to matter much for semaglutide exposure. The published…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #61 · Sourcing › Vendor reports · 24 Jan 2026 · 0 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. Two sources, same conclusion, and I could not rule…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #9 · Practice › Administration · 27 Dec 2025 · 22 likes Research-use-only preparations are not supplied with administration instructions because they are not supplied for administration. Anything in this subcategory…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #17 · Regional › UK & Ireland · 27 Dec 2025 · 18 likes The version of Private prescribing that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
What a stability-indicating method is and how you demonstrate one Started this topic · Analytics › Method validation · 26 Dec 2025 · 0 likes Asking directly, because I could not find a straight answer: What a stability-indicating method is and how you demonstrate one Posting a small dataset on…
Temperature loggers worth the money — the long version Replied, post #96 · Devices › Cold chain · 19 Dec 2025 · 4 likes Confirming post #95 from a second method, which matters more than confirming it from a second person. Assessing an excursion: if a package sat at room temperature for a…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #18 · Outcomes › Body composition · 22 Nov 2025 · 0 likes On Circumference measurements, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is…
Cross-border purchase rules within the EU Replied, post #41 · Regional › European Union · 19 Nov 2025 · 8 likes Where I have landed on cross-border purchase rules within, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a…
Managing an unplanned gap in supply — what changed since Replied, post #103 · Access › Shortages · 31 Oct 2025 · 4 likes Right — I had this wrong and I am glad to have read it before it mattered.
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #17 · Compounds › Tirzepatide · 28 Oct 2025 · 22 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
Payment mechanics and the recovery options that do not exist Replied, post #41 · Sourcing › Payments · 20 Oct 2025 · 0 likes What I would tell a new member reading about payment mechanics for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
A 40-week log with the measurement method stated Replied, post #17 · Outcomes › Progress reports · 15 Oct 2025 · 11 likes Nobody has said the unglamorous part of 40-week log yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Availability by country, dated, with primary sources Replied, post #17 · Access › International · 11 Oct 2025 · 0 likes Worth separating two things that post #16 runs together. Customs practice varies between entry points within the same country, which is why two people in the same…
Second pass at: Programming during a large energy deficit Replied, post #26 · Nutrition & Training › Resistance training · 3 Oct 2025 · 19 likes Post #22 and I disagree about the size of the effect, not about the direction. Post-weight-loss training: once weight loss is complete and energy deficit ends, training…
Substitution between formats during a shortage Replied, post #67 · Access › Shortages · 2 Oct 2025 · 0 likes This follows post #64 rather than contradicting it. My understanding of substitution between formats is a few years old and may have been superseded. If it has been, I…
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #6 · marked as the solution · Practice › Dosing & titration · 27 Sep 2025 · 20 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
High-resolution MS on aggregates and what it can see Replied, post #74 · Analytics › Mass spectrometry · 22 Sep 2025 · 0 likes Reporting rather than recommending, on high-resolution. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Gauge and length selection for subcutaneous injection Replied, post #30 · Devices › Syringes & needles · 15 Sep 2025 · 16 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. Speaking…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #40 · Practice › Storage & stability · 31 Aug 2025 · 1 like Adding the boring version of Freeze-thaw, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
When a preprint is the best available evidence and we say so Replied, post #108 · Evidence › Preprints · 28 Aug 2025 · 0 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors. That…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #38 · Compounds › Secretagogues & GH axis · 5 Aug 2025 · 3 likes I read post #36 twice before replying, because I had assumed the opposite. Effects reported at the level of appetite are the most consistently described and the most…
A ten-fold dose error caught before injection — one year on Replied, post #153 · Devices › Syringes & needles · 5 Aug 2025 · 0 likes Check what the graduations actually say rather than what you expect. A syringe marked in units and one marked in millilitres look similar at a glance and are not the…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #13 · Analytics › HPLC & UHPLC · 20 Jul 2025 · 22 likes A note on how Resolution and tailing factor gets discussed rather than on Resolution and tailing factor itself: the confident posts get the replies and the careful ones…
Managing an unplanned gap in supply — what changed since Replied, post #18 · Access › Shortages · 16 Jul 2025 · 20 likes Thank you for taking the time. That was more work than a reply usually is.
Second pass at: Reading a combination trial: attributing effect to components Replied, post #40 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2025 · 11 likes Post #36 describes the usual case. This is about the unusual one. Cagrilintide alone is discussed less than in combination because the published data is almost entirely…
About the Repair & healing peptides category Replied, post #5 · Compounds › Repair & healing peptides · 7 Jul 2025 · 24 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #38 · Pharmacology › Pharmacokinetics · 10 Jun 2025 · 0 likes Moving an injection by a day changes the concentration-time profile very little at these half-lives. It can change when somebody notices symptoms, which is a different…
Pre-registering a personal experiment, seriously Replied, post #65 · Research Methods › N-of-1 designs · 31 May 2025 · 9 likes Answering the question post #63 raises rather than the one it answers. An n of one tells you about one person, which is the person you are most interested in. That is…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #108 · Sourcing › Independent verification · 17 May 2025 · 4 likes Post #106 put the caveat in the right place and I want to underline it. Practical answer on Janoshik, since the theoretical one is upthread: do the simplest check…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #28 · Evidence › Trials · 12 May 2025 · 1 like Adding a note of thanks rather than an opinion. I did not know most of that.
Pages past their review date, listed — does this still hold? Replied, post #23 · Meta › Wiki maintenance · 10 May 2025 · 2 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #35 · Evidence › Journal club · 7 May 2025 · 26 likes Worth stating the null on STEP 4 before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Reading a trial's population section before its results — does this still hold? Replied, post #32 · Evidence › Trials · 23 Apr 2025 · 17 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Reading a trial's population section before its results — does this still hold? Replied, post #10 · Evidence › Trials · 14 Apr 2025 · 7 likes That is a fair summary of where the discussion has got to.
Storing a pen in use versus a pen unopened — what changed since Started this topic · Devices › Pens & autoinjectors · 15 Mar 2025 · 0 likes Posting this under the heading it deserves: Storing a pen in use versus a pen unopened — what changed since Everything below is what sits behind that. What changes if…
Coverage for the indication versus for the drug — a second dataset Replied, post #2 · Access › Insurance & coverage · 4 Mar 2025 · 16 likes Clear enough that I do not think I have a follow-up, which is unusual.
Journal club: SURMOUNT-1, read without the press release Replied, post #67 · Evidence › Journal club · 25 Feb 2025 · 0 likes Post #65 describes the usual case. This is about the unusual one. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
Telehealth prescribing models in the US Replied, post #58 · Regional › North America · 14 Feb 2025 · 4 likes Nothing to add, except that this is the answer I would give if asked.
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #74 · Compounds › Secretagogues & GH axis · 7 Feb 2025 · 7 likes Confirming post #72 from a second method, which matters more than confirming it from a second person. Published human data on most of this family is thin, old, or from…
What changed in 2026, by region Replied, post #33 · Access › International · 21 Dec 2024 · 0 likes Second this, and I would have said it less carefully.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #59 · Evidence › Journal club · 13 Dec 2024 · 0 likes The thing about SURPASS-2 that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Coming back to: When to suspect the method rather than the sample Replied, post #32 · Analytics › Method validation · 5 Dec 2024 · 19 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. The…
Why "any advice?" is the least effective ending for a post Replied, post #109 · Start Here › How to Ask · 5 Dec 2024 · 0 likes Fair, and the limits you put on it are the part I will remember.
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #14 · Compounds › Oral incretins · 2 Dec 2024 · 17 likes Everything in post #12 holds. The case it does not cover is the one I have. On variability: the between-person spread in exposure for oral semaglutide is wide enough…
Gallbladder disease risk with rapid weight loss Replied, post #30 · Clinical › Comorbidities · 12 Nov 2024 · 0 likes Everything in post #28 holds. The case it does not cover is the one I have. A note on how gallbladder disease risk gets discussed rather than on gallbladder disease…
Requesting a page: what makes a good request — what changed since Replied, post #74 · Documentation › Wiki requests · 11 Oct 2024 · 2 likes Requesting a page: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #75 · Practice › Administration · 3 Oct 2024 · 10 likes The practical value of a written technique note to yourself is that it survives a three-week gap. Everyone who has come back after a break has rediscovered something…
Irish differences from the UK position Replied, post #15 · Regional › UK & Ireland · 30 Sep 2024 · 27 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. Irish differences: I have looked for the primary source twice and failed twice.…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #33 · Nutrition & Training › Hydration & electrolytes · 9 Aug 2024 · 3 likes Taking post #32 at face value and following it one step further. I think the Sodium question is answerable and has not been answered, which is a more optimistic…
Second pass at: Journal club: LEADER as the historical anchor Replied, post #51 · Evidence › Journal club · 21 Jul 2024 · 0 likes Answering the question post #50 raises rather than the one it answers. Adding what did not work for me on LEADER, since the failures never get written up and they are…
The mass-error checker and its intended scope Replied, post #6 · Data & Tools › Calculators · 21 May 2024 · 11 likes Sensible. I would want the same detail before I acted on it either.